Clinical Trials
2 trialsNCT02927964 2024-10-16
TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma
Stanford University
Phase 1/2 Completed
NCT02254772 2019-11-27
A Phase I/II Study of Intratumoral Injection of SD-101
Stanford University
Phase 1/2 Completed